Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bio-Techne Corp shares valued at $63,705 were sold by Herr Amy E. on Jun 09 ’25. At $49.77 per share, Herr Amy E. sold 1,280 shares. The insider’s holdings dropped to 1,976 shares worth approximately $0.12 million following the completion of this transaction.
Also, JOSHUA MOLHO purchased 1,280 shares, netting a total of over 63,705 in proceeds.
Before that, Herr Amy E. had sold 1,860 shares from its account. In a trade valued at $122,691, the Director traded Bio-Techne Corp shares for $65.96 each. Upon closing the transaction, the insider’s holdings decreased to 1,860 shares, worth approximately $0.12 million.
Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in early July. As of May 30, 2025, Wells Fargo has initiated its “an Overweight” rating for TECH. Earlier on April 09, 2025, KeyBanc Capital Markets downgraded its rating. Their new recommendation was “a Sector weight” for TECH stock which previously was a “an Overweight”.
Analyzing TECH Stock Performance
On last trading session,, Bio-Techne Corp [NASDAQ: TECH] rose 5.71% to $58.47. The stock’s lowest price that day was $54.81, but it reached a high of $58.65 in the same session. During the last five days, there has been a surge of approximately 9.72%. Over the course of the year, Bio-Techne Corp shares have dropped approximately -24.82%. Shares of the company reached a 52-week high of $79.28 on 02/05/25 and a 52-week low of $46.01 on 04/21/25.
Support And Resistance Levels for Bio-Techne Corp (TECH)
According to the 24-hour chart, there is a support level at 55.97, which, if violated, would cause prices to drop to 53.46. In the upper region, resistance lies at 59.82. The next price resistance is at 61.16. RSI (Relative Strength Index) is 66.72 on the 14-day chart, showing neutral technical sentiment.
Is Bio-Techne Corp subject to short interest?
Stocks of Bio-Techne Corp saw a sharp steep in short interest on 2025-06-30 dropping by -1.22 million shares to 6.32 million. Data from Yahoo Finance shows that the short interest on 2025-05-30 was 7.54 million shares. A decline of -19.33% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.36 of the overall float, the days-to-cover ratio (short ratio) decline to 2.36.
Which companies own the most shares of Bio-Techne Corp (TECH)?
In terms of Bio-Techne Corp share price expectations, FactSet research, analysts set an average price target of 75 in the next 12 months, up nearly 35.6% from the previous closing price of $55.31. Analysts anticipate Bio-Techne Corp stock to reach 75 by 2025, with the lowest price target being 75. In spite of this, 7 analysts ranked Bio-Techne Corp stock as Buy at the end of 2025. On March 18, 2025, Evercore ISI assigned a price target of “an Outperform” to the stock and initiated coverage with a $75.
